|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2003
What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis
1 Dept Epidemiology and Public Health, Imperial College London, London, UK, 2 School of Public Health, University of Illinois at Chicago, Chicago, IL, USA, 3 Worldwide Epidemiology GlaxoSmithKline, Greenford, Middlesex and Health Promotion Research Unit, London School of Hygiene and Tropical Medicine, London, UK
CORRESPONDENCE: A. Hansell, Dept Epidemiology and Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London, W2 1PG, UK. Fax: 44 2074025253. E-mail: a.hansell@imperial.ac.uk
Keywords: asthma, cause of death, death certificates, epidemiology, obstructive lung diseases
Received: March 20, 2003
Accepted June 29, 2003
A. Hansell was funded by a Wellcome Trust Research Fellowship in Clinical Epidemiology.
Information on obstructive lung disease (OLD) deaths is generally derived from the underlying cause of death on the death certificate. This neglects information on other conditions mentioned and may underestimate the burden of disease.
Descriptive analyses of all conditions mentioned on the death certificate for all decedents where OLD (chronic obstructive pulmonary disease or asthma) was mentioned as a contributing cause of death were conducted for England and Wales for 1993–1999.
OLD was mentioned in 312,664 or 8.0% of all deaths. OLD comprised the underlying cause of death in 59.8% of deaths with any mention of OLD. Where OLD was not the underlying cause of death, the leading causes by the International Classification of Disease version 9 chapter were diseases of the circulatory system, neoplasms, and non-OLD diseases of the respiratory system. The top single causes were acute myocardial infarction, other ischaemic heart disease, and lung cancer.
The current analysis confirms that using the underlying cause of death underestimates the contribution of obstructive lung disease to mortality in England and Wales, in contrast to myocardial infarction where underlying cause of death captures most (94%) mentions on the death certificate.
This article has been cited by other articles:
|
|
 |
|
  M. Ekstrom, K. A. Franklin, and K. E. Strom Increased Relative Mortality in Women With Severe Oxygen-Dependent COPD Chest, January 1, 2010; 137(1): 31 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Zvezdin, S. Milutinov, M. Kojicic, M. Hadnadjev, S. Hromis, M. Markovic, and O. Gajic A Postmortem Analysis of Major Causes of Early Death in Patients Hospitalized With COPD Exacerbation Chest, August 1, 2009; 136(2): 376 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. de Torres, C. G. Cote, M. V. Lopez, C. Casanova, O. Diaz, J. M. Marin, V. Pinto-Plata, M. M. de Oca, H. Nekach, L. J. Dordelly, et al. Sex differences in mortality in patients with COPD Eur. Respir. J., March 1, 2009; 33(3): 528 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Godtfredsen, T. H. Lam, T. T. Hansel, M. E. Leon, N. Gray, C. Dresler, D. M. Burns, E. Prescott, and J. Vestbo COPD-related morbidity and mortality after smoking cessation: status of the evidence Eur. Respir. J., October 1, 2008; 32(4): 844 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Faustini, C. Marino, D. D'Ippoliti, F. Forastiere, V. Belleudi, and C. A. Perucci The impact on risk-factor analysis of different mortality outcomes in COPD patients Eur. Respir. J., September 1, 2008; 32(3): 629 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. de Torres, V. Pinto-Plata, C. Casanova, H. Mullerova, E. Cordoba-Lanus, M. Muros de Fuentes, A. Aguirre-Jaime, and B. R. Celli C-Reactive Protein Levels and Survival in Patients With Moderate to Very Severe COPD Chest, June 1, 2008; 133(6): 1336 - 1343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Chatila, B. M. Thomashow, O. A. Minai, G. J. Criner, and B. J. Make Comorbidities in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2008; 5(4): 549 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Brekke, T. Omland, S. H. Holmedal, P. Smith, and V. Soyseth Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation Eur. Respir. J., March 1, 2008; 31(3): 563 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe Complex chronic comorbidities of COPD Eur. Respir. J., January 1, 2008; 31(1): 204 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Han, V. V. McLaughlin, G. J. Criner, and F. J. Martinez Pulmonary Diseases and the Heart Circulation, December 18, 2007; 116(25): 2992 - 3005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Viegi, F. Pistelli, D. L. Sherrill, S. Maio, S. Baldacci, and L. Carrozzi Definition, epidemiology and natural history of COPD Eur. Respir. J., November 1, 2007; 30(5): 993 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dreher, J. H. Storre, and W. Windisch Noninvasive ventilation during walking in patients with severe COPD: a randomised cross-over trial Eur. Respir. J., May 1, 2007; 29(5): 930 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rudolf COPD and death: what exactly is the relationship? Thorax, May 1, 2007; 62(5): 378 - 379. [Full Text] [PDF]
|
|
|
|
|
|
L. P McGarvey, M. John, J. A Anderson, M. Zvarich, and R. A Wise Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee Thorax, May 1, 2007; 62(5): 411 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Soyseth, P. H. Brekke, P. Smith, and T. Omland Statin use is associated with reduced mortality in COPD Eur. Respir. J., February 1, 2007; 29(2): 279 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Sin, N. R. Anthonisen, J. B. Soriano, and A. G. Agusti Mortality in COPD: role of comorbidities Eur. Respir. J., December 1, 2006; 28(6): 1245 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A L Hansell Lies, damned lies and mortality statistics? Thorax, November 1, 2006; 61(11): 923 - 924. [Full Text] [PDF]
|
|
|
|
|
|
C Fuhrman, E Jougla, J Nicolau, D Eilstein, and M-C Delmas Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis Thorax, November 1, 2006; 61(11): 930 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Hurst, G. C. Donaldson, W. R. Perera, T. M. A. Wilkinson, J. A. Bilello, G. W. Hagan, R. S. Vessey, and J. A. Wedzicha Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 867 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. Jensen, N. S. Godtfredsen, P. Lange, and J. Vestbo Potential misclassification of causes of death from COPD Eur. Respir. J., October 1, 2006; 28(4): 781 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. G. Halpin and M. Miravitlles Chronic Obstructive Pulmonary Disease: The Disease and Its Burden to Society Proceedings of the ATS, September 1, 2006; 3(7): 619 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Marti, X. Munoz, J. Rios, F. Morell, and J. Ferrer Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur. Respir. J., April 1, 2006; 27(4): 689 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Lopez, K. Shibuya, C. Rao, C. D. Mathers, A. L. Hansell, L. S. Held, V. Schmid, and S. Buist Chronic obstructive pulmonary disease: current burden and future projections Eur. Respir. J., February 1, 2006; 27(2): 397 - 412. [Full Text] [PDF]
|
|
|
|
|
|
J. R. Hurst, W. R. Perera, T. M. A. Wilkinson, G. C. Donaldson, and J. A. Wedzicha Systemic and Upper and Lower Airway Inflammation at Exacerbation of Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 71 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Broekhuizen, E F M Wouters, E C Creutzberg, and A M W J Schols Raised CRP levels mark metabolic and functional impairment in advanced COPD Thorax, January 1, 2006; 61(1): 17 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Holguin, E. Folch, S. C. Redd, and D. M. Mannino Comorbidity and Mortality in COPD-Related Hospitalizations in the United States, 1979 to 2001 Chest, October 1, 2005; 128(4): 2005 - 2011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Sin and S. F. P. Man Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality Proceedings of the ATS, April 1, 2005; 2(1): 8 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W Q Gan, S F P Man, A Senthilselvan, and D D Sin Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis Thorax, July 1, 2004; 59(7): 574 - 580. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |